Product apis-gpcr-g-protein

Home > products > apis> gpcr-g-protein

Catalog	name	Description	price
R-R-3574	PSB-1115 CAS No.152529-79-8	PSB-1115/CAS No.152529-79-8 is a selective A2B Adenosine Receptor antagonist. PSB-1115 inhibits the 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced contraction inhibition of acetylcholine (ACh).	price>
R-R-3575	GP531 CAS No.142344-87-4	GP531/CAS No.142344-87-4 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.	price>
R-R-3576	Adenosine receptor antagonist 3 CAS No.2400864-80-2	Adenosine receptor antagonist 3/CAS No.2400864-80-2 is a potent antagonist of adenosine receptor. Adenosine receptor antagonist 3 has the potential for the research of cancer disease (extracted from patent WO2019233994A1, compound 1).	price>
R-R-3577	Inupadenant hydrochloride CAS No.2411004-22-1	Inupadenant (EOS-850) hydrochloride/CAS No.2411004-22-1 is an orally active, highly selective A2A receptor antagonist. Inupadenant hydrochloride is not brain-penetrant. Inupadenant hydrochloride has potent anti-tumor activity.	price>
R-C-1878	AZD-7594 CAS:1196509-60-0	AZD-7594(AZ13189620)is an inhaled selective glucocorticoid receptor(GCCR)modulator.AZD-7594 is in phase II clinical trials by AstraZeneca for the treatment of mild to moderate asthma.It is also in phase I clinical trials for the treatment of chronic obstructive pulmonary disorder(COPD).	price>
R-R-3578	Sipagladenant CAS No.858979-50-7	Sipagladenant (Compound I)/CAS No.858979-50-7 is an orally active adenosine receptor A2A inverse agonist. Sipagladenant can be used in frontal lobe dysfunction research.	price>
R-R-3579	SDZ-WAG994 CAS No.130714-47-5	SDZ-WAG994 (WAG-994)/CAS No.130714-47-5 is a stable, long-acting, selective and orally active A1-adenosine receptor agonist with a KD of 23 nM. SDZ-WAG994 can be used for the research of atrial fibrillation.	price>
R-R-3580	Alloxazine CAS No.490-59-5	Alloxazine/CAS No.490-59-5 is a selective A2b antagonist. Alloxazine completely block 5 N-Ethylcarboxamido adenosine (NECA)-mediated cyclic AMP accumulation with an IC50 of 2.9 μM. Alloxazine can be used for the research of cancer.	price>
R-R-3581	ST 1535 CAS No.496955-42-1	ST 1535/CAS No.496955-42-1 is a potent and orally active A2A adenosine receptor antagonist. ST 1535 shows antiparkinsonian activity and antitremorigenic effects. ST 1535 has the potential for the research of Parkinson disease.	price>
R-R-3582	Binodenoson CAS No.144348-08-3	Binodenoson (MRE-0470)/CAS No.144348-08-3 is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging.	price>

...

163